Anti-SLC34A2 (Lifastuzumab)-MC-Vc-PAB-SN38 Preis auf Anfrage

Catalog Number: TGM-T9901A-1093
Article Name: Anti-SLC34A2 (Lifastuzumab)-MC-Vc-PAB-SN38 Preis auf Anfrage
Biozol Catalog Number: TGM-T9901A-1093
Supplier Catalog Number: T9901A-1093
Alternative Catalog Number: TGM-T9901A-1093-1MG,TGM-T9901A-1093-5MG
Manufacturer: TargetMol
Category: Biochemikalien
Anti-SLC34A2 (Lifastuzumab)-MC-Vc-PAB-SN38 is an antibody-drug conjugate (ADC) composed of the human-derived anti-SLC34A2 (sodium-dependent phosphate transporter 2) antibody Lifastuzumab, linked with the Mc-VC-PAB connector and the topoisomeraseI inhibitor SN38. The ADCs cytotoxic component and linker are Mc-VC-PAB-SN38. This compound is utilized in cancer research.
Target: Antibody-Drug Conjugates (ADCs)|||Topoisomerase|||Sodium Channel